Glendale Neurological Associates P C

Glendale Neurological Associates P C was paid $52.64M by Medicaid between Jan 2018 and Dec 2024, across 66 billing codes. Its largest line is J2350, Injection, ocrelizumab, 1 mg — 38% of everything it billed.

33Billing provider infoGLENDALE NEUROLOGICAL ASSOCIATES P C
FARMINGTON HILLS, MI 48334

33aNPI1639134414assigned 04/18/2006

33bProvider typeInterventional Pain Medicine Physician

28Total paid$52.64M

24GClaims174,183

24DCodes billed66

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Interventional Pain Medicine Physician providers in Michigan

Rank by total paid#1 of 23

Median peer was paid$312K

This provider vs. median169×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,659	$3.73M
2019	21,479	$4.16M
2020	19,982	$5.00M
2021	25,589	$7.73M
2022	28,276	$9.85M
2023	31,836	$12.41M
2024incomplete	26,362	$9.75M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J2350	Injection, ocrelizumab, 1 mg	38%	1,001	910	$20.10M
J2323	Injection, natalizumab, 1 mg	26%	2,940	2,809	$13.60M
J0585	Injection, onabotulinumtoxina, 1 unit	13%	11,083	6,380	$6.59M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.1%	33,625	32,505	$2.14M
J0586	Injection, abobotulinumtoxina, 5 units	2.2%	1,388	1,165	$1.15M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.8%	10,652	10,602	$949K
95819		1.7%	6,335	6,106	$877K
99222	Initial hospital care, per day, moderate complexity	1.2%	8,646	8,415	$634K
70551	Magnetic resonance imaging, brain; without contrast material	1.2%	5,482	5,465	$622K
95816		1.1%	2,730	2,721	$555K
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	1.0%	13,155	6,020	$539K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.0%	11,954	11,767	$537K

54 more codes

70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.0%	3,120	$528K
99215	Doctor's office visit, returning patient (complex)	<1%	5,118	$448K
99205	Prolong outpt/office vis	<1%	3,827	$427K
64615		<1%	5,026	$356K
99223	Prolong inpt eval add15 m	<1%	3,248	$342K
95886		<1%	3,405	$303K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,729	$246K
72141		<1%	1,765	$171K
J3032	Injection, eptinezumab-jjmr, 1 mg	<1%	51	$165K
95911		<1%	1,230	$151K
72156		<1%	799	$133K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	2,228	$125K
64405		<1%	2,201	$121K
64642		<1%	2,179	$115K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	934	$98K
62323		<1%	732	$96K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	3,076	$69K
64643		<1%	1,802	$67K
95913		<1%	402	$65K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	3,470	$43K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,512	$31K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,121	$27K
70544		<1%	280	$27K
96415		<1%	1,178	$26K
92250		<1%	942	$18K
99203	Doctor's office visit, new patient (routine)	<1%	247	$16K
95953		<1%	61	$14K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,143	$12K
92133		<1%	529	$11K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	299	$8K
95874		<1%	353	$8K
95910		<1%	78	$8K
72146		<1%	80	$8K
A9585	Injection, gadobutrol, 0.1 ml	<1%	294	$7K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	211	$7K
20552		<1%	254	$5K
62321		<1%	38	$5K
95909		<1%	63	$5K
64400		<1%	50	$5K
72157		<1%	25	$5K
81025		<1%	930	$4K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	325	$4K
99221		<1%	58	$3K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,776	$1K
96361	Intravenous infusion, hydration; each additional hour	<1%	215	$1K
62270		<1%	13	$957.78
64616		<1%	13	$892.54
99284	Emergency room visit (serious)	<1%	13	$841.17
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	843	$740.61
J7050	Infusion, normal saline solution, 250 cc	<1%	1,342	$693.95
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	354	$458.57
92134		<1%	185	$233.81
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	12	$24.16
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOUDOURIS, WILLIAM (PRESIDENT)